| Bioactivity | Bexotegrast is a potent inhibitor of ανβ6 integrin. Bexotegrast can be used for researching fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP) (extracted from patent WO2020210404A1, compound 5)[1]. |
| Name | Bexotegrast |
| CAS | 2376257-44-0 |
| Formula | C27H36N6O3 |
| Molar Mass | 492.61 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Jacob CHA, et al. Dosage forms and regimens for amino acid compounds. Patent WO2020210404A1. |
Bexotegrast
CAS: 2376257-44-0 F: C27H36N6O3 W: 492.61
Bexotegrast is a potent inhibitor of ανβ6 integrin. Bexotegrast can be used for researching fibrosis such as idiopath
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.